Zobrazeno 1 - 10
of 1 541
pro vyhledávání: '"Phase IV"'
Autor:
Lexchin J; School of Health Policy and Management, York University, Toronto, ON, Canada.; Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada., Dong BM; School of Journalism and Communication, Carleton University, Ottawa, ON, Canada., Ramanathan A; School of Public Policy & Administration, Carleton University, Ottawa, ON, Canada., Gagnon MA; School of Public Policy & Administration, Carleton University, Ottawa, ON, Canada.
Publikováno v:
International journal of health policy and management [Int J Health Policy Manag] 2024; Vol. 13, pp. 8239. Date of Electronic Publication: 2024 Apr 08.
Autor:
Trailokya A; Head, Department of Medical Affairs, Indoco Remedies Limited, Mumbai, Maharashtra, India, Corresponding Author., Srivastava A; Consultant, Clinical Research and Drug Development, Ahmedabad, Gujarat, India., Mukaddam Q; Independent Pharma Consultant, Department of Solutions, Edenwell Therapeutics Private Limited, Mumbai, Maharashtra, India., Chaudhry S; Director and Consultant, Department of Solutions, Edenwell Therapeutics Private Limited, Mumbai, Maharashtra, India., Patel K; Head, Department of Medical and Health Technology, Lupin Limited, Mumbai, Maharashtra, India., Suryawanshi S; Director, Medical Services Emcure Pharmaceutical Ltd., Mumbai, Maharashtra, India., Naik M; Head, Department of Clinical Operations and Pharmacovigilance, Edenwell Therapeutics Private Limited, Mumbai, Maharashtra, India.
Publikováno v:
The Journal of the Association of Physicians of India [J Assoc Physicians India] 2024 Jan; Vol. 72 (1), pp. 85-87.
Autor:
Hamidi H; Division of Cardiology, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA., Bagheri M; Division of Cardiology, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA., Benzing T; Division of Cardiology, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA., Krishnan S; Division of Cardiology, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA., Kianoush S; Division of Cardiology, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA., Ichikawa K; Division of Cardiology, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA., Ghanem AK; Division of Cardiology, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA., Javier D; Division of Cardiology, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA., Iskander B; Division of Cardiology, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA., Aldana-Bitar J; Division of Cardiology, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA., Budoff MJ; Division of Cardiology, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA. Electronic address: mbudoff@lundquist.org.
Publikováno v:
American heart journal [Am Heart J] 2024 Dec; Vol. 278, pp. 24-32. Date of Electronic Publication: 2024 Aug 24.
Autor:
Stewart S; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain., Seco-Meseguer E; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain., Diago-Sempere E; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain., Marín-Candón A; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain., Carmona M; Unidad de Investigación en Telemedicina y e-Salud, Instituto de Salud Carlos III, Madrid, Spain., Estébanez M; Internal Medicine Department, Hospital Central de la Defensa Gomez Ulla, Madrid, Spain., López-Fernández LA; Pharmacy Department, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Maranon, Madrid, Spain.; Plataforma SCReN (Spanish Clinical Research Network), Madrid, Spain., Imaz-Iglesia I; Health Technology Assessment Agency (AETS), Instituto de Salud Carlos III, Madrid, Spain.; Red de Investigación en Servicios de Salud en Enfermedades Crónicas, Madrid, Spain., Del Mar García Saiz M; Clinical Pharmacology Service, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain., Laserna-Mendieta EJ; Department of Gastroenterology, Research Unit, Hospital General de Tomelloso, Tomelloso, Castilla-La Mancha, Spain.; Instituto de Investigación Sanitaria de Castilla La Mancha, Toledo, Castilla La Mancha, Spain., Peiró AM; Unidad de Farmacología Clínica, Unidad del Dolor, Alicante Department of Health-General Hospital, Alicante, Comunidad Valenciana, Spain., Farré M; Department of Clinical Pharmacology, Pharmacogenomics Unit, Hospital Germans Trias i Pujol, Badalona, Catalunya, Spain.; Department of Pharmacology, Universitat Autonoma de Barcelona, Cerdanyola del Vallès, Catalunya, Spain., Rodriguez-Jimenez C; Clinical Trials Unit, Pharmacology Department, Hospital Universitario de Canarias, La Laguna, Canarias, Spain.; Complejo Hospital Universitario de Canarias, UICEC, La Laguna, Spain., Saiz-Rodriguez M; Research Unit, Fundación Burgos por la Investigación de la Salud, Hospital Universitario de Burgos, Burgos, Spain., Sanabria-Cabrera J; Servicio de Farmacología Clínica, IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain, Platform for Clinical Research and Clinical Trials IBIMA, Hospital Universitario Virgen de la Victoria, Malaga, Andalucía, Spain., Rosas-Alonso R; Pharmacogenetics Laboratory, Genetics Department, Hospital Universitario La Paz, Madrid, Spain., Abad-Santos F; UICEC Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria La Princesa (IP), Hospital Universitario de la Princesa, Madrid, Spain., Pedrosa L; Health Technology Assessment Agency (AETS), Instituto de Salud Carlos III, Madrid, Spain., Carcas AJ; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain., García García I; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain., Borobia AM; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain alberto.borobia@salud.madrid.org.; Pharmacology Department. School of Medicine, Autonomous University of Madrid, Madrid, Spain.
Publikováno v:
BMJ open [BMJ Open] 2024 Nov 07; Vol. 14 (11), pp. e089823. Date of Electronic Publication: 2024 Nov 07.
Autor:
Taichman DB, Drazen JM
Publikováno v:
The New England journal of medicine [N Engl J Med] 2024 Sep 19; Vol. 391 (11), pp. 1050-1051. Date of Electronic Publication: 2024 Sep 10.
Autor:
Eustes AS; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Ahmed A; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Swamy J; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Patil G; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Jensen M; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Wilson KM; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Kudchadkar S; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Wahab A; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Perepu U; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Miller FJ Jr; Department of Internal Medicine, Vanderbilt University Medical Center and VA Medical Center, Nashville, Tennessee, USA., Lentz SR; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Dayal S; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA; Iowa City VA Healthcare System, Iowa City, Iowa, USA. Electronic address: sanjana-dayal@uiowa.edu.
Publikováno v:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Sep; Vol. 22 (9), pp. 2514-2530. Date of Electronic Publication: 2024 May 28.
Autor:
Janda GS; Yale School of Medicine, New Haven, CT, USA., Jeffery MM; Division of Health Care Delivery Research, Mayo Clinic, Rochester, MN, USA., Ramachandran R; Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.; Yale Collaboration for Regulatory Rigor, Integrity, and Transparency, Yale School of Medicine, New Haven, CT, USA., Ross JS; Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.; Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, CT, USA.; Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA., Wallach JD; Yale Collaboration for Regulatory Rigor, Integrity, and Transparency, Yale School of Medicine, New Haven, CT, USA. joshua.wallach@emory.edu.; Department of Epidemiology, Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA, 30322, USA. joshua.wallach@emory.edu.
Publikováno v:
BMC medical research methodology [BMC Med Res Methodol] 2024 Aug 28; Vol. 24 (1), pp. 187. Date of Electronic Publication: 2024 Aug 28.
Autor:
Kreutziger J; Medical University Innsbruck, Innsbruck, Austria dietmar.fries@i-med.ac.at., Ulmer H; Medical University Innsbruck, Innsbruck, Austria dietmar.fries@i-med.ac.at., Fries D; Medical University Innsbruck, Innsbruck, Austria dietmar.fries@i-med.ac.at.
Publikováno v:
The New England journal of medicine [N Engl J Med] 2024 Aug 22; Vol. 391 (8), pp. 772-773.
Autor:
Yates SG; University of Texas Southwestern Medical Center, Dallas, TX sean.yates@utsouthwestern.edu., Sarode R; University of Texas Southwestern Medical Center, Dallas, TX sean.yates@utsouthwestern.edu.
Publikováno v:
The New England journal of medicine [N Engl J Med] 2024 Aug 22; Vol. 391 (8), pp. 773-774.
Autor:
Wong ML; Lewis Katz School of Medicine at Temple University, Philadelphia, PA matthew.wong@tuhs.temple.edu.
Publikováno v:
The New England journal of medicine [N Engl J Med] 2024 Aug 22; Vol. 391 (8), pp. 773.